Evercore ISI Starts vTv Therapeutics (VTVT) at Outperform, 'essentially a single-asset story'
Evercore ISI analyst Michael DiFiore initiates coverage on vTv Therapeutics (NASDAQ: VTVT) with a Outperform rating and a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)